Nicotinamide Riboside (NR)
SupplementThe small divergence between the medical score [s2, s8, s9] and the community score [c1, c3] reflects that both the study evidence and user experiences point to moderate and inconsistent efficacy. The community is more skeptical than is typical for longevity supplements, mirroring the scientific caution [c2, c5].
Unlock full information
Dosages, side effects, studies and more — free after registration.
Register for freeRating Scales
TL;DR
NR reliably raises NAD⁺ in the blood — that's the one finding that has been consistently replicated. Whether that increase actually reaches relevant tissues and translates into clinical benefit remains unclear after multiple RCTs on insulin resistance, muscle function, and cognition. The community is divided: some report subtle energy improvements, many others notice nothing after months of use. Given the high cost, lack of long-term data, and an unresolved debate around potential cancer promotion, NR is not a compelling buy for healthy adults right now.
Description
Nicotinamide riboside (NR) is a vitamin B3 derivative and NAD⁺ precursor shown to increase NAD⁺ levels; clinical benefit in humans remains largely unclear [s1, s2].
Nicotinamide riboside (NR) is a pyridine nucleoside and naturally occurring form of vitamin B3 that is converted in the body into nicotinamide adenine dinucleotide (NAD⁺) via two enzymatic steps [s1, s3]. NAD⁺ is a central coenzyme in energy metabolism, involved in DNA repair (via PARP enzymes) and in the activation of sirtuins (particularly SIRT1) [s4, s5]. With advancing age, tissue NAD⁺ levels decline, leading to impairments in mitochondrial function and cellular energy supply [s5]. NR is considered a more efficient NAD⁺ precursor than simple niacin, as it can be directly phosphorylated by nicotinamide riboside kinase (NRK1/2) [s3]. Clinical studies in humans consistently demonstrate that oral NR doses of 250 mg to 2000 mg daily significantly increase NAD⁺ levels in blood and peripheral blood mononuclear cells (PBMCs) [s6, s7]. Whether this increase is sufficiently pronounced in relevant tissues (muscle, brain, liver) and can be translated into clinically meaningful endpoints (muscle strength, cognition, insulin sensitivity) is not established based on current evidence [s2, s7, s8, s9]. NR is approved in the EU as a novel food, holds FDA GRAS status, and demonstrates good short-term tolerability up to 2000 mg/day over 12 weeks in safety studies [s6, s10]. Long-term data beyond 12 weeks are currently lacking [s2].
Legal Status (DE)
In the EU, nicotinamide riboside chloride has been approved as a novel food since January 2020 under Regulation (EU) 2020/16 and may be legally sold as a dietary supplement [s14, s15]. In the DACH countries, NR is therefore available over the counter as a dietary supplement. In the USA, NR chloride holds GRAS status (GRAS Notice GRN 000635, since 2016) [s13].
Mechanism of Action
Following oral absorption, NR is phosphorylated to nicotinamide mononucleotide (NMN) by nicotinamide riboside kinase 1 and 2 (NRK1/2). NMN is subsequently converted to NAD⁺ by NMN adenylyl transferase (NMNAT) [s3]. This pathway is referred to as the salvage pathway and is considered a direct route to intracellular NAD⁺ elevation [s1, s3]. NAD⁺ fulfills several key functions in the organism: 1. Energy metabolism: NAD⁺ acts as an electron carrier in glycolysis, the citric acid cycle, and the mitochondrial respiratory chain [s5]. 2. Sirtuin activation: NAD⁺ is an essential cofactor for the NAD⁺-dependent deacetylases SIRT1–7. SIRT1 modulates, among other things, mitophagy, mitochondrial biogenesis (via PGC-1α), and inflammatory responses [s4, s5]. 3. PARP activation: Poly(ADP-ribose) polymerases (PARPs) consume NAD⁺ for DNA strand break repair. Sufficiently high NAD⁺ levels support this process [s4]. 4. CD38 regulation: CD38 is an NAD⁺-hydrolyzing enzyme whose activity increases with age and contributes to NAD⁺ decline. NR supplementation can counteract this decline [s4]. In animal studies, NR protects against high-fat diet-induced obesity and improves metabolic flexibility via SIRT1 activation [s4]. These effects have not yet been reproduced in humans [s8, s9].
Dosing
NAD⁺-Erhöhung (allgemein, Erwachsene)
- Dose
- 250–500 mg
- Frequency
- 1× täglich morgens
- Route
- oral
- Duration
- fortlaufend
- Timing
- Morning, with or without meal
- With food
- optional
NAD⁺-Erhöhung (höhere Dosis, klinische Studien)
- Dose
- 500 mg twice daily (1000 mg/day)
- Frequency
- 2× täglich
- Route
- oral
- Duration
- 6–12 Wochen
- Timing
- Morning and midday; avoid evening dosing due to potential sleep disturbances
- With food
- optional
Sicherheitsobergrenze (geprüft in RCTs)
- Dose
- up to 2000 mg/day
- Frequency
- aufgeteilt auf mehrere Dosen
- Route
- oral
- Duration
- bis 12 Wochen (Studiendauer)
- Timing
- Split throughout the day
- With food
- optional
In clinical studies, doses of up to 2000 mg/day were tolerated over 12 weeks without serious adverse events [s10]. The EU novel food authorization defines specific quantity restrictions for dietary supplements pursuant to Regulation (EU) 2020/16 [s14]. No established upper limits exist for long-term daily use.
Some users recommend taking NR in the morning, as anecdotal reports describe sleep-disrupting effects with evening administration [c1, c3]. Clinical studies have not systematically investigated this.
Side Effects
| Side Effect | Frequency | Severity |
|---|---|---|
| Übelkeit, Bauchbeschwerden, Durchfall Occasionally reported in RCTs at doses up to 2000 mg/day; generally mild and transient [s10]. | gelegentlich | leicht |
| Flush (Hautrötung, Hitzegefühl) Less frequent than with niacin (nicotinic acid), as NR does not trigger the niacin flush mechanism via prostaglandins; occasionally reported [s10, s11]. | selten | leicht |
| Kopfschmerzen Documented as an occasional adverse effect in clinical safety studies [s10]. | gelegentlich | leicht |
| Schlafstörungen (Einschlafprobleme) Reported anecdotally by community users with evening dosing; not systematically investigated in RCTs [c1, c3]. | selten | leicht |
| Methyl-Depletion (theoretisch) NR metabolism consumes methyl groups via SAM (S-adenosylmethionine). Theoretical concern with long-term use without adequate methyl donor supplementation (e.g., betaine, choline); not clinically established [c2, s11]. | theoretisch | moderat |
| Potenzielle Förderung von Tumorwachstum (theoretisch) Preclinical evidence suggests elevated NAD⁺ levels may support tumor cell growth. Not clinically established in humans, but relevant as a precautionary consideration [s11, c5]. | theoretisch | schwer |
Contraindications
Theoretical risk that NAD⁺ elevation may promote tumor metabolism and proliferation; preclinical data available, clinical data lacking. Use without oncological consultation not recommended [s11, c5].
No clinical safety data available for pregnancy and lactation. Use not recommended [s10].
No clinical safety data available for this age group [s10].
Theoretically, NAD⁺ elevation could modulate immune activation; clinical relevance unclear [s11].
Interactions
Synergistic
Frequently combined, as resveratrol activates SIRT1 and NR provides NAD⁺ levels. Synergism is mechanistically plausible [s5]; clinical evidence is lacking.
Methyl donors could theoretically counteract methyl depletion caused by NR metabolism [c2, s11].
NR and pterostilbene (NRPT) have been combined in several RCTs and significantly elevated NAD⁺ levels. NR provides NAD⁺ for all seven sirtuins, while pterostilbene additionally activates SIRT1.
Apigenin inhibits CD38, a NAD⁺-consuming enzyme, while NR directly raises NAD⁺ levels. In animal studies, the combination synergistically increased hippocampal NAD⁺ and reduced neuroinflammation.
Quercetin is discussed as a CD38 inhibitor and may thereby slow NAD⁺ degradation, while NR increases NAD⁺ synthesis. The combination is used in longevity protocols; clinical evidence is still lacking.
NR and ALCAR both support mitochondrial function via complementary pathways – NR through NAD⁺-dependent processes and ALCAR through fatty acid transport into mitochondria.
NR and CoQ10 are frequently combined in mitochondrial medicine, as NAD⁺ and CoQ10 are both essential cofactors of the mitochondrial respiratory chain. A clinical study in chronic kidney disease investigated this combination.
Resveratrol activates SIRT1, while NR elevates NAD⁺ levels, which are required as a necessary cofactor for sirtuin activity. The combination could synergistically enhance cellular protective effects via the sirtuin signaling pathway, though clinical evidence is still lacking.
NR metabolism can consume methyl groups; concomitant TMG supplementation may counteract this effect and maintain methylation balance. At standard NR doses this is generally unnecessary, but may be advisable at higher doses.
Fisetin acts as a senolytic and reduces the burden of senescent cells, while NR supports NAD⁺-dependent cellular energy production and DNA repair. The combination is used in longevity protocols, though clinical data are lacking.
PQQ promotes mitochondrial biogenesis via PGC-1α, while NR activates the same pathway via NAD⁺/SIRT1. Both compounds are used complementarily in mitochondrial medicine.
Caution
Theoretical risk that NAD⁺ elevation could reduce the efficacy of certain DNA-damaging chemotherapeutics (which rely on NAD⁺ consumption by PARP) [s11].
Combination frequently used in the biohacker community; interactions not systematically studied [c1].
Berberine activates AMPK and influences NAD⁺/SIRT1 metabolism similarly to NR. Concomitant use could theoretically lead to overlapping effects on energy metabolism; systematic data are lacking.
Both alpha-lipoic acid and NR influence mitochondrial redox processes and energy metabolism. Concomitant high-dose use could theoretically lead to overlapping effects on redox status; systematic human interaction data are lacking.
Studies
Tier A — High Evidence
Outcome: NAD⁺ levels in peripheral blood mononuclear cells (PBMCs)
Effect Size: 500 mg NR twice daily increased NAD⁺ levels in PBMCs by approximately 60% versus placebo
Outcome: Insulin sensitivity (hyperinsulinemic euglycemic clamp) in obese men
Effect Size: No significant improvement in insulin sensitivity at 2000 mg/day NR
Outcome: Cognitive function in mild cognitive impairment (MCI)
Effect Size: No significant effect on primary cognitive endpoints
Outcome: NAD⁺ metabolome in blood and skeletal muscle
Effect Size: Significant increase in NAD⁺ metabolome; anti-inflammatory transcriptional signature in muscle
Tier B — Moderate Evidence
Outcome: Safety and efficacy of NAD precursors in various clinical conditions
Effect Size: No serious adverse events at up to 2000 mg/day over 12 weeks
Outcome: Skeletal muscle mass and function under NMN/NR in older adults
Effect Size: Evidence remains inconclusive; no consistent effect on muscle function demonstrated
Tier C — Low Evidence
Outcome: Protection against high-fat diet-induced obesity, SIRT1 activation
Effect Size: Significant improvement of metabolic parameters in mice; transferability to humans unclear
Community Evidence
Top reported benefits
- Subtle energy improvement and reduced fatigue (especially in Long COVID)
- Improved general well-being with prolonged use
- Combination with NMN or resveratrol as a popular longevity stack
- Better tolerability compared to NMN or direct NAD⁺ infusions
Top reported issues
- Many users report no perceptible effects after weeks or months
- High cost with uncertain benefit
- Concerns about possible methyl depletion with long-term use
- Anecdotal reports of sleep disturbances when taken in the evening
Prominent longevity researchers and physicians (e.g., Peter Attia) have described NR as a waste of money, as it did not extend lifespan in the NIA Interventions Testing Program and potential cancer promotion cannot be excluded [c5]. Concern about methyl depletion with long-term use is widespread in the community but not clinically established [c2]. Discussions about actual tissue penetration of NR (whether blood NAD⁺ increases reach tissue) are frequent [c3, c4].
Scientific Sources
- Nicotinamide riboside - Wikipedia
Wikipedia contributors (2024). WikipediaCLink - Evaluation of safety and effectiveness of NAD in different clinical conditions: a systematic review
Mehmel M, Jovanović N, Spitz U, et al. (2023). American Journal of Physiology – Endocrinology and MetabolismADOI - Possible Adverse Effects of High-Dose Nicotinamide
Knip M, Douek IF, Moore WP, et al. (2000). PMCBLink - Precursor comparisons for the upregulation of nicotinamide adenine dinucleotide. Novel approaches for better aging
Shade C (2020). Integrative Medicine (Encinitas)BLink - Agency Response Letter GRAS Notice No. GRN 000635 – Nicotinamide riboside chloride
U.S. Food and Drug Administration (2016). FDAALink - Commission Implementing Regulation (EU) 2020/16 authorising the placing on the market of nicotinamide riboside chloride as a novel food
European Commission (2020). Official Journal of the European UnionALink - NMN in Deutschland: Rechtslage, EU Novel Food und Zugang (2026)
Longevity Germany (2026). Longevity Germany (longevity-germany.com)CLink - The Effect of Nicotinamide Mononucleotide and Riboside on Skeletal Muscle Mass and Function: A Systematic Review and Meta-Analysis
Not individually listed in search results, et al. (2025). PMC / PubMedAPMID:40275690 - The emergence of the nicotinamide riboside kinases in the regulation of NAD+ metabolism
Ratajczak J, Joffraud M, Trammell SA, et al. (2016). PMCBLink - The NAD+ precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity
Cantó C, Houtkooper RH, Pirinen E, et al. (2012). Cell MetabolismCPMID:22682224DOI - Nicotinamide Riboside, a Promising Vitamin B3 Derivative for Healthy Aging and Longevity: Current Research and Perspectives
Mehmel M, Jovanović N, Spitz U, et al. (2023). Molecules (MDPI)BDOI - Nicotinamide riboside augments the aged human skeletal muscle NAD+ metabolome and induces transcriptomic and anti-inflammatory signatures
Elhassan YS, Kluckova K, Fletcher RS, et al. (2019). Cell ReportsADOI - What is really known about the effects of nicotinamide riboside supplementation in humans
Brakedal B, Dölle C, Riemer F, et al. (2023). Science AdvancesADOI - A randomized placebo-controlled clinical trial of nicotinamide riboside in obese men: safety, insulin-sensitivity, and lipid-mobilizing effects
Dollerup OL, Christensen B, Svart M, et al. (2018). American Journal of Clinical NutritionAPMID:29992272DOI - A randomized placebo-controlled trial of nicotinamide riboside in older adults with mild cognitive impairment
Hou Y, Huang M, Kocot M, et al. (2024). PMCALink
Community Sources
Storage
Unopened
Store in a dry, cool location, protected from direct sunlight and moisture, at room temperature (15–25 °C).
Opened
Keep container tightly closed; avoid moisture. Use within 6 months of opening.
Notes
NR chloride is hygroscopic and may clump upon moisture exposure. Follow manufacturer instructions.